[1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005; 115:209-18.10.1172/JCI2428254643515690074]Search in Google Scholar
[2. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen- producing cells of normal rat liver. Proc Natl Acad Sci USA. 1985; 82: 8681-5.10.1073/pnas.82.24.86813915003909149]Open DOISearch in Google Scholar
[3. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001; 21:311-35.10.1055/s-2001-1755011586463]Open DOISearch in Google Scholar
[4. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000; 275:2247-50.10.1074/jbc.275.4.224710644669]Search in Google Scholar
[5. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science. 2003; 299:890-3.10.1126/science.107956212574630]Search in Google Scholar
[6. Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, et al. Proangiogenic role of tumoractivated hepatic stellate cells in experimental melanoma metastasis. Hepatology. 2003; 37:674-85.10.1053/jhep.2003.5006812601365]Open DOISearch in Google Scholar
[7. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Hepatic fibrosis: molecular mechanisms and drug targets. Ann Rev Pharm Toxicol. 2005; 45:605-28.10.1146/annurev.pharmtox.45.120403.09590615471534]Open DOISearch in Google Scholar
[8. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med. 2004; 10:429-34.10.1038/nm100615152612]Open DOISearch in Google Scholar
[9. Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis. 2004; 36:231-42.10.1016/j.dld.2004.01.00315115333]Open DOISearch in Google Scholar
[10. Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatology. 1999; 29: 1818-24.10.1002/hep.51029060110347125]Open DOISearch in Google Scholar
[11. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology 2002; 122:1399-410.10.1053/gast.2002.3299511984526]Search in Google Scholar
[12. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002; 35:762-71.10.1053/jhep.2002.32029293519311915021]Open DOISearch in Google Scholar
[13. Hopkins AL, Groom CR. The druggable genome. Nature Rev Drug Discov. 2002; 1:727-30.10.1038/nrd89212209152]Search in Google Scholar
[14. Shin MS, Kang EH, Lee YI. A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes. Antiviral Res. 2005; 67: 163-8.10.1016/j.antiviral.2005.06.00516118024]Search in Google Scholar
[15. Papadopoulos V, Kapsis A, Li H, Amri H, Hardwick M, Culty M, et al. Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells. Anticancer Res. 2000; 20:2835-47.]Search in Google Scholar
[16. Dewint P, Gossye V, De Bosscher K, Vanden Berghe W, Van Beneden K, Deforce D, et al. A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis. J Immunol 2008; 180: 2608-15.10.4049/jimmunol.180.4.260818250472]Search in Google Scholar
[17. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2011; 39:D38-51.10.1093/nar/gkq1172301373321097890]Open DOISearch in Google Scholar
[18. Poornima C, Asif SM, Amir Asad A, Vibhika G, Jitendra S, Singh R. Homology modeling and active site analysis of leptin receptor of homo sapiens involved in obesity. Int J Appl Biol Pharm Technol. 2010; 1:747-53.]Search in Google Scholar
[19. Schwede T, Kopp J, Guex N, Peitsch MC. SWISSMODEL: an automated protein homology-modeling server. Nucleic Acids Res. 2003; 31:3381-5.10.1093/nar/gkg52016892712824332]Open DOISearch in Google Scholar
[20. Guex N, Peitsch MC. SWISS-MODEL and the Swiss- PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997; 18:2714-23.10.1002/elps.11501815059504803]Open DOISearch in Google Scholar
[21. Peitsch MC. Protein modeling by E-mail. Biol Technol. 1995; 13:658-60.10.1038/nbt0795-658]Open DOISearch in Google Scholar
[20. Bhattacharya A, Tejero R, Montelione GT. Evaluating protein structures determined by structural genomics consortia. Proteins. 2007; 66:778-95.10.1002/prot.2116517186527]Search in Google Scholar
[21. DeLano WL. The PyMOL molecular graphics system. 2002 (http://www.ccp4.ac.uk/newsletters/newsletter40.pdf#page=44).]Search in Google Scholar
[22. Laurie AT, Jackson RM. Q-SiteFinder: An energy-based method for the prediction of protein-ligand binding sites. Bioinformatics. 2005; 21:1908-16.10.1093/bioinformatics/bti315]Open DOISearch in Google Scholar
[23. Kaiser J. Chemists want NIH to curtail database. Science. 2005; 308:774.10.1126/science.308.5723.774a]Search in Google Scholar
[24. Bolton EE, Kim S, Bryant SH. PubChem3D: Diversity of shape. J Cheminform. 2011; 21:3-9.10.1186/1758-2946-3-9]Search in Google Scholar
[25. Macindoe G, Mavridis L, Venkatraman V, Devignes MD, Ritchie DW. HexServer: an FFT-based protein docking server powered by graphics processors. Nucleic Acids Res. 2010; 38:W445-9.10.1093/nar/gkq311]Open DOISearch in Google Scholar
[26. Fallowfield JA, Kendall TJ, Iredale JP. Reversal of fibrosis: no longer a pipe dream? Clin Liver Dis. 2006; 10:481-97.10.1016/j.cld.2006.08.022]Open DOISearch in Google Scholar
[27. Sherman IA, Pappas SC, Fisher MM. Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis. Am J Physiol. 1990; 258:H460-5.10.1152/ajpheart.1990.258.2.H460]Search in Google Scholar
[28. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008; 371:838-51.10.1016/S0140-6736(08)60383-9]Search in Google Scholar
[29. Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol. 2004; 1:98-105.10.1038/ncpgasthep0055]Search in Google Scholar
[30. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005; 115:209-18.10.1172/JCI24282]Search in Google Scholar
[31. Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol. 2005; 3:95-107.10.1016/S1542-3565(04)00445-8]Open DOISearch in Google Scholar
[32. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis. 2001; 21:437-51.10.1055/s-2001-17558]Open DOISearch in Google Scholar
[33. Wu J, Danielsson A. Inhibition of hepatic fibrogenesis: a review of pharmacologic candidates. Scand J Gastroenterol. 1994; 29:385-91.10.3109/00365529409096827]Open DOISearch in Google Scholar
[34. Guner OF. The impact of pharmacophore modeling in drug design. IDrugs. 2005; 8:567-72.15973565]Search in Google Scholar
[35. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-32.10.1038/372425a0]Search in Google Scholar
[36. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor, OB-R.Cell. 1995; 83:1263-71.10.1016/0092-8674(95)90151-5]Open DOISearch in Google Scholar
[37. White DW, Tartaglia LA. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev. 1996; 7:303-9.10.1016/S1359-6101(96)00040-8]Open DOISearch in Google Scholar
[38. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, et al. Crystal structure of the obese protein leptin-E100. Nature. 1997; 387:206-9.10.1038/387206a0]Search in Google Scholar
[39. Kline AD, Becker GW, Churgay LM, Landen BE, Martin DK, Muth WL, et al. Leptin is a four-helix bundle: secondary structure by NMR. FEBS Lett. 1997; 407:239-42.10.1016/S0014-5793(97)00353-0]Search in Google Scholar
[40. Hiroike T, Higo J, Jingami H, Toh H. Homology modeling of human leptin/leptin receptor complex. Biochem Biophys Res Commun. 2000; 275:154-8.10.1006/bbrc.2000.3275]Search in Google Scholar
[41. Bogan AA, Thorn KS. Anatomy of hot spots in protein interfaces. J Mol Biol. 1998; 280:1-9.10.1006/jmbi.1998.1843]Search in Google Scholar
[42. Mallat A, Lotersztajn S. Multiple hepatic functions of endothelin-1: physiopathological relevance. J Hepatol. 1996; 25:405-13.10.1016/S0168-8278(96)80130-9]Open DOISearch in Google Scholar
[43. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem. 2000; 275:715-22.10.1074/jbc.M006577200]Search in Google Scholar
[44. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, et al. Ligands of peroxisome proliferatoractivated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterol. 2000; 119:466-78.10.1053/gast.2000.9365]Search in Google Scholar
[45. Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, et al. Peroxisome proliferatoractivated receptor gamma transcriptional regulation is involved in plateletderived growth factor-induced proliferation of human hepatic stellate cells. Hepatol. 2000; 31:101-8.10.1002/hep.510310117]Open DOISearch in Google Scholar
[46. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati- Baroni G, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterol. 2002; 122: 1924-40.10.1053/gast.2002.33666]Search in Google Scholar
[47. Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatol. 1999; 29: 1818-24.10.1002/hep.510290601]Open DOISearch in Google Scholar
[48. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterol. 2002; 122: 1399-410.10.1053/gast.2002.32995]Search in Google Scholar
[49. Ernst E. Harmless herbs? A review of the recent literature. Am J Med. 1998; 104:170-8.10.1016/S0002-9343(97)00397-5]Search in Google Scholar
[50. De Smet PA. Herbal remedies. N Engl J Med. 2002; 347:2046-56.10.1056/NEJMra02039812490687]Search in Google Scholar
[51. Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001; 135:262-8.10.7326/0003-4819-135-4-200108210-0001111511141]Search in Google Scholar
[52. Strader DB, Bacon BR, Lindsay KL, La Breque DR, Morgan T, Wright EC, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol. 2002; 97:2391-7.10.1111/j.1572-0241.2002.05993.x12358262]Search in Google Scholar
[53. Flora KD, Rosen HR, Brenner KG. The use of neuropathic remedies for chronic liver disease. Am J Gastroenterol. 1996; 91:2654-5. ]Search in Google Scholar